Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:approvedBy |
gptkb:Japan
|
| gptkbp:ATCCode |
B03XA12
|
| gptkbp:brand |
Mujinzo
|
| gptkbp:CASNumber |
1092939-17-7
|
| gptkbp:developedBy |
gptkb:Bayer
|
| gptkbp:hasInChIKey |
QJQYQJXKQKJZQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C19H16N4O4
|
| gptkbp:hasSMILES |
C1=CC=C(C=C1)C(=O)NC2=NC(=C(N=C2C3=CC=CC=C3)C(=O)N)C(=O)O
|
| https://www.w3.org/2000/01/rdf-schema#label |
Molidustat
|
| gptkbp:indication |
anemia associated with chronic kidney disease
|
| gptkbp:legal_status_in_Japan |
approved
|
| gptkbp:mechanismOfAction |
HIF prolyl-hydroxylase inhibitor
|
| gptkbp:molecularWeight |
364.36 g/mol
|
| gptkbp:PubChem_CID |
25154816
CHEMBL2103887 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:target |
HIF prolyl-hydroxylase
|
| gptkbp:therapeuticArea |
nephrology
|
| gptkbp:UNII |
6Z1Y2V4S2E
|
| gptkbp:usedFor |
treatment of anemia
|
| gptkbp:bfsParent |
gptkb:Servier
|
| gptkbp:bfsLayer |
7
|